Risk identification for quality on stage of pharmaceutical development of combined eye drops for glaucoma treatment

Risk identification for quality on stage of pharmaceutical development of combined eye drops for glaucoma treatment

<p><strong>Aim:</strong> To identify the possible risks associated with critical quality attribute of combined eye drops for the treatment of glaucoma using of common risk evaluation methodologies for plannig a drug quality on the stage of pharmaceutical development. <strong>...

Full description

Bibliographic Details
Main Authors: Олександр Миколайович Якубчук, Світлана Володимировна Русанова, Олена Геннадіївна Фетісова, Лариса Миколаївна Андрюкова, Володимир Костянтинович Яковенко
Format: Article
Language:English
Published: PC Technology Center 2015-12-01
Series:ScienceRise
Subjects:
drug
pharmaceutical development
QbD
critical quality attribute
risk assessment
CH Q9
Online Access:http://journals.uran.ua/sciencerise/article/view/56944

Internet

http://journals.uran.ua/sciencerise/article/view/56944

Similar Items